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Drug Administration has approved two different graft
configurations for endoluminal aneurysm repair. In several
personal series, short-term results are well documented,
and the procedure seems reasonably safe as reported in
national and even larger international registries.1-8
Nevertheless, several factors restrict the widespread
use of the procedure, the most important being disease
specific (such as anatomy, thrombus deposition, calcified
plaque formation at the proximal, and distal attachment
sites located within the aorta and iliac arteries).9
Tortuosity and aneurysmal disease of the iliac arteries can
be limiting factors for endograft placement. The signifi-
cance of reperfusion or continued perfusion of the
aneurysmal sac through sidebranches (such as accessory
renal arteries, the inferior mesenteric artery [IMA], lum-
bar branches and the hypogastric artery) is still a matter of
debate.10 Most of the grafts currently commercially avail-
able are modular, thereby allowing greater versatility; but
the necessary graft-graft connections play a major role in
the development of late type III leaks and graft deteriora-
tion.11,12 There is limited experience with long-term
behavior of the thin-walled grafts exposed to pulsatile flow
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Purpose: Endograft technology for abdominal aortic aneurysm (AAA) repair is being applied more liberally. There is little
information about the midterm performance of these grafts. This study is focused on follow-up interventions after endo-
graft repair for AAA.
Methods: Prospective follow-up analysis of a consecutive patient series (n = 173 patients) at a single center who underwent
endovascular AAA repair up to 50 months after operation. Seventeen percent of the patients were regarded unfit for open
surgery. Four types of commercially available grafts were used. The Society for Vascular Surgery/International Society for
Cardiovascular Surgery guidelines were applied for endograft implantation and data preparation.
Results: In two patients, the procedure was converted to open surgery. In one procedure, emergency repair for iliac artery
rupture was performed. The 30-day mortality rate was 2.8% (n = 5 patients). An early second procedure to correct type I
endoleaks was necessary in 8 cases (4.6%; 3-10 days). The following midterm results were obtained: median follow-up of
the 166 remaining patients was 18 months (range, 1-50 months); 50 additional procedures were necessary in 37 patients
(22.3%) for the treatment of leaks (n = 45 interventions) or to maintain graft patency (n = 5 grafts; four patients with
concomitant graft segment disconnection); and 46% of the reinterventions were performed within the first year of follow-
up and 74% of the reinterventions were performed within the second year of follow-up. One patient died after emergency
surgery for rupture as the result of a secondary endoleak at 1 year. Although seven interventions (14%) were performed
for type II endoleak, no serious complications were related to patent sidebranches. There was no statistically significant
difference between the need for maintenance in different graft configurations (tubular, bifurcated, aorto-uniiliac), or
number of graft segments (1, 2, 3-4, ≥5 segments). New generation grafts (after 1996) performed better than early gen-
eration grafts (P = 0.04, chi-squared test) with regard to endoleak development.
Conclusion: Endograft repair for AAA is safe but, with current technology, not as durable as open repair. Our data sug-
gest that the use of endograft repair for AAA is becoming safer as endograft design improves. Nevertheless in 26.6% of
the patients, there is need for reintervention within midterm follow-up. Close follow-up is crucial because late leaks may
develop after more than 2 years after the initial procedure. Endoluminal repair should therefore be applied with caution,
strict indication, and only if a tight follow-up is warranted. These findings may also affect health care reimbursement poli-
cies. (J Vasc Surg 2001;33:S46-54.)
Graft replacement is accepted as the standard of care
for aortic aneurysm treatment. In selected patients with
infrarenal abdominal aortic aneurysms (AAAs), endovas-
cular treatment has become increasingly accepted as a fea-
sible alternative to open surgery.1 Recently, the Food and
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Table I. Endovascular grafts used in this series from March 1995 through December 1999, listed chronologically
Configuration Current status
Time Graft n Bifurcated Tubular Aorto-moniiliac Europe United States
March 1995-May 1996 Stentor 30 18 12 0 ca, dc ep, dc
June 1996-Nov 1997 Vanguard I 72 64 8 0 ca, wd ep, dc
Dec 1996-Dec 1999 Talent* 15 9 0 6 ca ep
Oct 1997-Nov 1999 Vanguard II 13 13 0 0 ca, wd ep, wd
Oct 1998-Dec 1999 Excluder 38 38 0 0 ep, ca ep
Nov 1999-Dec 1999 Zenith† 3 3 0 0 ca ep
ca, Commercially available; dc, discontinued; ep, experimental protocol; wd, withdrawn from market.
*World Medical, Sunrise, Fla.
†Cook, Brisbane, Australia.
within the graft or the aneurysm sac. Constant friction
between the stent-skeleton and the graft may cause wear of
the thin-walled grafts and lead to secondary leaks. Recent
reports of stent instability because of knot breakage and
nitinol deterioration at junctions are a major concern.12,13
The endograft also has to comply with a variety of mor-
phologic alterations (such as shrinkage or dilatation of the
aneurysmal sac in the transverse axis and elongation versus
constriction in the longitudinal axis).14,15 It is a matter of
discussion whether rigid or compliant grafts will perform
better with regard to graft-associated leaks and adaptation
to morphologic changes of the aneurysm sac.12,13
The purpose of this study was to evaluate midterm
outcome of endovascular AAA treatment in a consecutive
series of patients who were treated and followed uniformly
at a single university teaching hospital.
METHODS
Evaluation of a consecutive series of patients who
underwent endovascular treatment of an AAA from March
1995 through December 1999 with the use of modular
stented endovascular graft technology was performed
(Table I). Our technique of graft implantation and its
assembly has been previously described in detail.2,3
Data collection and follow-up protocol. Data were
collected in a prospective manner as part of the Eurostar pro-
tocol.1,16 All patients in the endovascular aneurysm treatment
registry from the very beginning are numbered in consecutive
order; therefore, the numbers given in the text or in the fig-
ures refer to the respective patient. Patients were subjected to
a strict follow-up protocol that required a contrast spiral com-
puted tomography (CT) scan and laboratory testing after the
operation and at 3, 6, and 12 months after the operation and
yearly thereafter. Color-coded duplex scans were obtained in
addition at 1 month and, in most instances, at the same time
intervals as the CT scan. After 1 year, duplex scanning was per-
formed biannually. Additional investigations were obtained
whenever indicated during the follow- up period (eg, to fol-
low leaks more closely). Each patient included in this series
had completed at least 1 month of follow-up.
Table II. Patient characteristics of the 173 patients who underwent endovascular AAA repair from March 1995
through December 1999
Characteristic Risk factors (%) 0 1 2 3
Sex (M/F) 155/18
Age (y)
Median 73.2
Range 51.9-86.9
ASA score
II 2.9
III 53.2
IV 43.9
Unfit for open repair (%) 17.3
Risk factors (%)*
Smoking 14.5 21.4 16.8 47.3
Hypertension 13.8 32.4 45.7 8.1
Diabetes 78.6 16.8 4.0 0.6
Hyperlipidemia 23.7 57.8 10.4 8.1
Cardiac 22.5 23.1 43.4 11.0
Cerebrovascular 46.2 41.0 5.8 6.9
Pulmonary 24.3 41.0 33.5 1.2
*Rutherford R, Flannigan D, Gupta S, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg
1986;4:80-94.
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Reporting standards. Patients who underwent
endovascular repair expressed their informed consent to the
experimental nature of the procedure, and the program was
conducted under the supervision of the institutional ethics
committee. The aneurysms were classified according to both,
the European and US classification.16,17 The endovascular
grafts were used and implanted according to the recom-
mended guidelines of the ad hoc Endovascular Graft
Committee of The Society for Vascular Surgery/International
Society for Cardiovascular Surgery.17-19
Operative procedures. All procedures were per-
formed by the same team of surgeons and interventional-
ists. Initially, only patients fit for open surgery received
endografts, but later in the series, patients with no clear-
ance for surgery underwent operation. Clearance for
surgery was judged by a medical specialist on the basis of
general risk factors that are summarized in Table II. The
procedure was performed in a special operating room
facility that was equipped with a ceiling-mounted image
intensifier and a radiolucent operating room table.
Definition of success. A successful procedure was
defined as a completed endovascular procedure that
demonstrated either no primary type-I endoleak, graft
occlusion, or run-off thrombosis within 30 days. Within
follow-up, the following events were collected: redo inter-
vention for primary leak, redo intervention for secondary
endoleak (type I-IV20), or redo intervention for graft
thrombosis. No interventions were performed so far for
type V endoleak (endotension21).
Imaging studies evaluation. For the purpose of this
study the postoperative imaging studies (spiral contrast
CT, intravenous angiography, conventional angiography,
magnetic resonance angiography, and color duplex stud-
ies), outpatient charts and readmission charts within the
follow-up of these patients were reevaluated.
RESULTS
From March 1995 through December 1999, 173
patients underwent endovascular treatment of an AAA.
Details of their clinical presentation at surgery can be
found in Table II. The mean diameter of the aneurysms
treated was 5.5 ≤ cm (range, 4.5-9.0 cm). Patients with
small abdominal aneurysms (≤5 cm) either showed rapid
growth of more than 1 cm per year in maximum diameter
or with combined iliac aneurysmal disease as the main
indication for surgery. Details of aneurysm morphologic
condition are given in Table III. In two patients (patients
23 and 28), the endovascular procedure was converted to
open surgery because of graft delivery problems. In one
patient (patient 153), emergency repair for iliac artery
rupture during implantation was performed. Although the
endovascular graft was left in place, the patient died of
multiorgan failure 2 days after the rescue procedure.
Postmortem examination showed an intact graft and no
evidence of leak. The overall 30-day operative mortality
rate was 2.95% (patients 43, 125, 141, 153, and 162). The
average time between surgery and death was 4.8 days
(range, 1-8 days). Patients 23 and 28 were omitted from
further calculations.
Early result. One hundred seventy patients underwent
postoperative CT scans and intravenous angiography or
color-coded duplex sonography to evaluate the patency of
the graft and the large adjacent sidebranches (renal arteries,
hypogastric arteries) and the presence of endoleaks.
Nineteen graft-associated leaks (11.2%) were identified.
There were 16 type I leaks (9.4%), seven of which were at
the proximal attachment site and nine of which were at the
distal attachment site. There were three leaks arising from
disrupted graft-graft connections (type III; 1.8%). In these
patients, eight early interventions were performed in eight
patients (4.7%) to correct six type I leaks and two type III
endoleaks. All patients received additional endografts to
extend the graft either proximally or distally or to recon-
nect stent segments. In one case (patient 113), a left acces-
sory renal artery and, in another case (patient 168), the left
main renal artery were intentionally covered with the graft.
There were no known permanent renal sequellae in either
patients. In the remaining 11 cases (6.4%), the leak seemed
small, and close observation was felt to be safe.
Thirty-seven type II leaks were detected in 26 patients
(15.3%), 20 of which were arising from the IMA, 13 of
which were arising from lumbar arteries, and four of which
were from accessory renal arteries. In nine patients, there
were two branches patent. There was one leak that reper-
Table III. Aneurysm characteristics in the 173 patients
who underwent endovascular AAA repair from March
1995 through December 1999
Aneurysm* configuration n %
European classification†
A 27 15.6
B 74 42.8
C 27 15.6
D 18 10.4
E 27 15.6
United States classification‡
I 27 15.6
Iia 69 39.9
Iib 77 44.5
III 0 —
IV 0 —
Stage I 151 87.3
Stage II 12 12.7
Stage III 0 —
Stage IV 0 —
*Size, 55 mm; range, 45-90 mm.
†Harris P, Buth J, Mialhe C, et al. The need for clinical trials of
endovascular abdominal aortic aneurysm repair: the Eurostar
Project. J Endovasc Surg 1997;4:72-7.
‡Ahn S, Rutherford R, Johnston K, et al. Reporting standards for
infrarenal endovascular abdominal aortic aneurysm repair. J Vasc
Surg 1997;25:405-10.
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fused an accessory renal artery, with channels both to a
lumbar artery and the IMA in a patient with a horseshoe
kidney. All patients with a type II leak were treated with
observation. There was no statistical correlation between
the number of graft segments or the used graft configura-
tion with regard to primary leak at discharge.
Mid-term result. The mean follow-up period of the
remaining 166 patients was 18 months (range, 1-50
months). Fifteen patients died during follow up, one of
these deaths occurred after an emergency repair for sec-
ondary rupture because of a type III leak more than 14
months after stent graft insertion (patient 77). The sec-
ondary rupture rate of this series is 1 of 166 patients
(0.6%). In the remaining 14 deceased patients, there was
one small type I leak at the proximal graft fixation and one
type II leak arising from the IMA. Neither of these
patients died of aneurysm rupture as confirmed by
autopsy.
Overall there were 50 procedures necessary in 37
patients after the initial stent graft procedure, either for
treatment of leaks (n = 45 procedures) or to symptomatic
graft occlusion (n = 5 procedures), in four of these cases
concomitant graft segment disconnection was found to be
the reason for graft occlusion. Leaks were treated, if the
leak increased in size or if there was any change in
aneurysm morphologic condition. Occlusions were
treated, if they were symptomatic only.
Type I leaks. There were 17 type I leaks that were
treated with 19 interventions, four leaks at the proximal
and 15 leaks at the distal graft attachment site. Proximal
leaks were treated with extension only; distal leaks in the
aortic position were treated by conversion of the tubular
repair into a bifurcated one, placing the second graft inside
the old graft.22 Distal leaks within the iliac arteries were
treated with distal extension only or with simultaneous
hypogastric embolization and extension of the graft into
the external iliac artery (n = 4 leaks). Type I leaks were
either primary (n = 6 leaks) or secondary (n = 9 leaks).
Most of the distal secondary type I leaks were caused by
retraction of the graft limbs out of the common iliac artery
(Fig 1).
Type II leaks. Five type II leaks were treated with
eight interventions. In all of these patients, the leak was
known since the postoperative CT scan, and enlargement
of the leak was demonstrated. In six instances, the leak was
arising from the IMA, and in one instance, the leak arose
from a large lumbar branch. Closure of the endoleak was
attempted by percutaneous embolization in all instances
first. The IMA was approached through the superior
mesenteric artery, and coils were placed into the ostium of
the IMA (Fig 2). In two instances, the leak reappeared and
a second embolization was attempted. In one patient
(patient 82, with retroperitoneal haematoma), the second
embolization failed again, and laparoscopic ligation of the
Fig l. A, Secondary type I endoleak caused by the retraction of the right iliac limb into the aneurysm sac (patient 3). B, The right graft
limb was extended deep into the common iliac artery.
A B
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IMA was performed. A CT scan 3 months after surgery
showed no contrast in the aneurysm sac outside the graft.
In one case, a large lumbar artery was embolized success-
fully through the hypogastric artery.
Type III leaks. Twelve type III leaks were identified,
which required 16 interventions. One patient had sec-
ondary rupture (patient 77). In the other cases, repair of
type III leaks consisted of engaging the separated graft
segments with a guidewire and reconnecting them with a
covered stentgraft (Fig 3). Usually an uncovered stent was
placed at the distal end to prevent further migration of the
distal graft segment (Fig 4). All patients who received
thrombolysis for graft occlusions that were identified with
a concomitant leak (n = 4 patients) had type III leaks.
Type IV leaks. There were four type IV leaks that
were identified that required 6 interventions. Repair con-
sisted of overstenting with a covered stent alone. All cases
of type IV leaks were observed in patients in the very early
group grafts(Stentor; Mintec, Freeport, Bahamas). In this
series, only leaks at limbs were observed, not in the body
of the graft (Fig 5).
Type V leaks. There are two patients with growth of the
aneurysm sac, but reperfusion of the sac could not be
demonstrated. No action has been taken so far in these
patients, because the growth of the aneurysm is slow and the
general condition of the patients does not allow open repair.
Graft thrombosis. Graft thrombosis was observed in
eight patients (4.8%). Five patients had symptoms that
required five interventions. Four patients were treated
with thrombolysis, revealing a type III endoleak in all of
them that was corrected with a second procedure. In one
patient (patient 61) a femorofemoral crossover graft was
placed 6 weeks after the initial surgery because of graft
thrombosis on the side of insertion. The reason for throm-
bosis was a kink in the graft without any evidence of leak.
Timing of the reinterventions. Because experience
in this series is ongoing, the number of patients being fol-
lowed for more than 4 years is increasing. Nevertheless, 23
reinterventions were performed within the first year of fol-
low up (46% of all reinterventions; 102 patients at risk at
12 months). Fourteen interventions were performed
within the second year (at risk at 24 months, 50 patients).
In patients with a longer follow-up, the number of rein-
terventions per year seem to be constant, but the number
of interventions (24-36 months, 10 interventions; 26-48
months, 2 interventions; ≥48 months, 1 intervention) and
of the patients at risk is low (≥ 36 months, 22 patients;
≥48 months, 6 patients).
Influence of graft configuration. There was no sta-
tistically significant difference between the need for main-
tenance in different graft configurations (tubular,
bifurcated, aorto-uniiliac), but the number of tubular and
aorto-uniiliac grafts in this series is small (Table I). There
was no influence of the number of graft units used for each
procedure (1, 2, 3-4, ≥5).
Influence of graft type. New generation grafts
implanted after 1996 (Table I) performed better than
early generation grafts (Stentor or early Vanguard I;
Boston Scientific, Galway, Ireland) with regard to leaks of
type I, III, and IV (P = .04, chi-squared test).
DISCUSSION
A consecutive clinical series with abdominal infrarenal
aortic aneurysm from one single center is presented. Early
Fig 2. A, Primary type II endoleak arising from the IMA (patient 59). The leak was enlarging during follow-up. B, Successful emboliza-
tion was performed by way of the superior mesenteric artery.
A B
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results are comparable with contemporary series that deal
with endograft technology for AAA repair.2,5,7,20 Despite the
technical feasibility to insert a graft into the aorta, sufficient
sealing is not always achieved. Even though all cases were
carefully selected and the endograft procedure was deemed
feasible on preoperative evaluation, more than 11% of the
patients had primary graft associated leaks. Furthermore,
21.8% of the patients had patent sidebranches with blood
drainage into the aneurysm sac. The treatment of primary
leaks is a matter of discussion. Immediate surgical conver-
sion, secondary endovascular treatment, or observation is
reported in the literature.22-25 Graft-associated leaks may seal
spontaneously.6 Nevertheless, the durability of spontaneous
sealing is not always guaranteed, and leaks may reoccur dur-
ing follow-up at the same site.26 A thrombosed leak still
transmitting arterial blood pressure into the aneurysm sac27
is extremely difficult to identify. In addition, some of these
leaks can be very small initially and can be obscured by calci-
fications within the aortic wall. Type I leaks increase in size
rather early because of graft migration and show rapid
increase within the first 6 months after operation. It is our
policy to correct all type I leaks immediately, if they are visu-
alized in the early phase of the postoperative contrast CT
scan. Late enhancement of the sac can be caused by type II
leaks and are treated with observation.
A surprisingly large number of type II leaks were
detected on postoperative CT scan in this series (21.8%). It
may be of help to leave a catheter inside the aneurysm sac
after graft deployment to rule out high-pressure type II
leaks7 or to fill the aneursym sac with a thrombosing agent.28
During follow-up, some of the IMA leaks may seal off spon-
taneously, especially if they are small. Lumbar leaks may form
a dorsal channel either horizontally or vertically. The signifi-
cance of dorsal channel perfusion of the aneurysm sac is cur-
rently unclear.10 Lumbar leaks seldom drain into the
aneurysm sac, unless there is another patent branch to drain
the blood (eg, IMA or an accessory renal artery). They are
difficult to approach either by endovascular means or open
surgery. In our experience, only graft-associated leaks require
immediate correction.
Within the first year after surgery, most authors recom-
mend a tight follow-up scheme, involving both duplex scan-
ning and CT scanning. Our follow-up protocol adheres to
the recommendations of Eurostar, which require four
planned imaging studies within the first year.1 Thus, type I
and type II leaks can be followed very closely, and most of
the reinterventions during this time period are performed for
these types. Type III leaks are rather uncommon during the
first year of follow-up, unless major abdominal or thoracic
surgery is undertaken. Overextension of the abdomen dur-
ing thoracotomy in the lateral decubitus position or manip-
ulation within the abdomen may cause the stent-stent
connections to disrupt. We observed this problem in two
instances (patients 54 and 77). Both patients had the same
type of graft, and disruption was observed at the trailing end
of the short contralateral limb. Newer generation grafts have
a longer overlap, which makes graft disruptions less likely.
Leaks after a longer follow-up were predominantly type
I, III, and IV leaks. The large number of type I leaks may be
explained by our early practice to place the iliac limbs only
with a short overlap of about 1 cm into the common iliac
artery (Fig 4). In the case of aneurysm sac shortening, the
graft29 gives way anteriorly, and the iliac limb may slip out of
the common iliac artery. Since this problem has been recog-
nized, the distal ends of the graft are now placed distal into
the common iliac artery, close to the iliac bifurcation. The
same process seems to be responsible for type III leaks.
Stentor and Vanguard grafts have very short overlapping
zones at the bifurcation. All but one type III leaks were
observed in patients who were treated with this type of graft.
During the first 2 years of this series, extra grafts were sel-
dom available, and therefore the overlap between grafts was
rather short to reach the distal attachment site with as few
graft segments as possible. This practice has now been aban-
doned, and the overlaps are chosen generously (≥3 cm).
The graft-graft connections can be additionally stabilized by
oversizing of the distal graft. Barbs or hooks for fixation
may be appealing but cause tears in the thin-walled grafts.
Graft-graft connections can be avoided by the implantation
of prefabricated bifurcated grafts. Yet, these grafts require
Fig 3. The principle of endoleak type III treatment: reconnection
of the separated stent graft segments and prevention of further
distal graft migration with an uncovered stent.
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cumbersome manipulations within the aneurysm sac, and
deployment of the contralateral limb is difficult. These
grafts are not stent supported, and late stenosis caused by
kinking of the graft limbs is a common problem.6,13,30
Type IV leaks were observed in the early graft genera-
tion only (Stentor grafts were withdrawn from the market
in 1996). This problem has already been recognized, and
the sutures within the body of the graft and the iliac limbs
have been eliminated.12,13 Nevertheless, the stent structure
of the Stentor-Vanguard grafts becomes rather unstable, if
the ties break while keeping the stent segments together.
This will cause increased wearing of the graft and piercing
of the stent through the graft wall.12,31 This can be elimi-
nated either by placing the stent skeleton on the outside of
the graft or by increasing the thickness of the graft material.
There are ongoing improvements of the manufacturers in
all grafts used in this series, so the impact of the improve-
ments are difficult to identify.
There was a reduction of the overall number of reinter-
ventions observed in grafts implanted after 1996. Yet, this
finding is difficult to explain and may be multifactorial.
Graft introduction systems improved, which facilitated graft
insertion significantly. Graft design and composition has
changed, with the stent skeleton being on the outside
(Excluder; Gore, Palo Alto, Calif) rather than on the inside.
Case selection may have played a role in obtaining better
results.
Most of the interventions in this series occurred dur-
ing the first and second year of follow-up. This is not sur-
prising because, during this time, the correction of
primary leaks were performed. Secondary leaks can be
Fig 4. Primary type III endoleak. The reason for endoleak in this
case is the extensive tortuosity of the left common iliac artery
(patient 104). Several stent segments were used in a thrombone-
like fashion to reach the left external iliac artery. A, Plain abdom-
inal radiograph clearly shows the separated grafts. B and C,
Reconnection with a covered stent was performed.  
A
B
C
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 2 Hölzenbein et al S53
detected as early as 6 months after operation. Leaks caused
by graft degeneration have been identified so far after
more than 3 years of follow-up and with one type of graft
only. It is difficult to identify grafts that will need mainte-
nance. There are usually no symptoms that indicate the
presence of an endoleak and the need of urgent repair.
Most of the clinical decisions are made after an apparently
routine CT scan or duplex finding. Therefore, continuing
surveillance is a prerequisite for endografting.
Although endovascular repair may be appealing for the
patient and the surgeon, a word of caution is necessary.
Endovascular graft placement has been proved to be tech-
Fig 5. Type IV endoleak. This endoleak was observed 38 months after graft insertion (patient 8). A, Separation of the stent structure
can be appreciated in the CT-scan. B and C, The leak was closed with a long covered stent.
A
B C
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nically feasible, yet it is not as durable as open repair.
Tight follow-up is necessary, because leaks may appear
even after periods of more than 2 years. Surveillance pro-
tocols are essential, to recognize problems early and to
prevent secondary rupture. It is still a matter of debate
whether to correct late endoleaks by open repair or by
endovascular means. It is our experience that open proce-
dures after stent placement are technically challenging for
a variety of reasons.25 It is necessary to keep patients and
physicians informed that maintenance procedures may be
necessary. This raises questions about whether the proce-
dure is cost effective. There are different reports on peri-
operative costs, which suggest similar costs or a slight
advantage for the endovascular repair.32-34 In midterm
follow-up, endovascular repair seems to be more expensive
because of the need of frequent imaging and the rather
expensive maintenance procedures. In times of shortage of
means and increasing health care costs, this may have an
impact on health care reimbursement policies.
We thank Johannes Heuer for graphic support.
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